Cargando…

Real-world effectiveness and safety of oral anticoagulation strategies in atrial fibrillation: a cohort study based on a German claims dataset

OBJECTIVE: To compare the real-world effectiveness and safety of non-vitamin-K-antagonist oral anticoagulant (NOAC) treatment in atrial fibrillation (AF) patients with a vitamin-K-antagonist (VKA)-based treatment. METHODS: This was a retrospective analysis of an anonymized claims dataset from 3 Germ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mueller, Sabrina, Groth, Antje, Spitzer, Stefan G, Schramm, Anja, Pfaff, Andreas, Maywald, Ulf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935078/ https://www.ncbi.nlm.nih.gov/pubmed/29750067 http://dx.doi.org/10.2147/POR.S156521

Ejemplares similares

Vitamin-K-antagonist phenprocoumon versus direct oral anticoagulants in patients with atrial fibrillation: a real-world analysis of German claims data
por: Warkentin, Lisette, et al.
Publicado: (2023)

Real-world treatment of German patients with recurrent and advanced endometrial cancer with a post-platinum treatment: a retrospective claims data analysis
por: Mevius, Antje, et al.
Publicado: (2022)

Evaluating the Economic Burden of Relapses in Neuromyelitis Optica Spectrum Disorder: A Real-World Analysis Using German Claims Data
por: Knapp, Rachel K., et al.
Publicado: (2021)

Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis
por: Buhl, Roland, et al.
Publicado: (2022)

Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data
por: Warkentin, Lisette, et al.
Publicado: (2022)

Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation
por: Patti, Giuseppe, et al.
Publicado: (2023)

Patient characteristics, adherence, and costs of oral anticoagulation therapy in non-valvular atrial fibrillation using the Dubai Real-World Claims Database
por: El Kadri, Moutaz, et al.
Publicado: (2021)

Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation
por: Calderon, Jose Miguel, et al.
Publicado: (2022)

Correction to: Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation
por: Patti, Giuseppe, et al.
Publicado: (2023)

Decision of Anticoagulation in Nonvalvular Atrial Fibrillation in the Real World in the Non-Antivitamin K Anticoagulants Era
por: Gheorghe, Gabriela Silvia, et al.
Publicado: (2022)

Identifying the Causes Increasing the Risk of Non-Adherence in Adult Patients with Asthma: An Analysis Combining Patient Survey Data with German Claims Data
por: Müller, Sabrina, et al.
Publicado: (2021)

COVID‐19 and Anticoagulation for Atrial Fibrillation: An Analysis of US Nationwide Pharmacy Claims Data
por: Hernandez, Inmaculada, et al.
Publicado: (2021)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Left Atrial Appendage Closure in Atrial Fibrillation: A World without Anticoagulation?
por: Contractor, Tahmeed, et al.
Publicado: (2011)

Real-world study of direct oral anticoagulant dosing patterns in patients with atrial fibrillation
por: Gustafson, Whitney L., et al.
Publicado: (2019)

Semantic computational analysis of anticoagulation use in atrial fibrillation from real world data
por: Bean, Daniel M., et al.
Publicado: (2019)

Use of Oral Anticoagulation in a Real‐World Population With Device Detected Atrial Fibrillation
por: Kaplan, Rachel M., et al.
Publicado: (2020)

Real-world outcomes associated with switching to anti-TNFs versus other biologics in Crohn’s Disease patients: A retrospective analysis using German claims data
por: Zhuleku, Evi, et al.
Publicado: (2022)

EPH144 The Impact of COVID-19 Pandemic on the Detection and Management of Cancer: A German Claims Data Analysis
por: Mevius, A, et al.
Publicado: (2022)

POSA52 A Year-on-Year Comparison Overall German Healthcare Resource Utilization in COVID Versus Non-COVID Times: A German Claims Data Analysis
por: Mevius, A, et al.
Publicado: (2022)

Patient Preferences for Oral Anticoagulation Therapy in Atrial Fibrillation: A Systematic Literature Review
por: Wilke, Thomas, et al.
Publicado: (2016)

Liver disease epidemiology and burden in patients with alterations in plasma protein metabolism: German retrospective insurance claims analysis
por: Picker, Nils, et al.
Publicado: (2023)

Preferences for and use of oral anticoagulants for stroke prevention in atrial fibrillation under real-world conditions in Germany: A survey among physicians
por: Mocek, Anja, et al.
Publicado: (2022)

Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis
por: Hardtstock, Fränce, et al.
Publicado: (2020)

Epidemiology, healthcare utilization, and related costs among patients with IPF: results from a German claims database analysis
por: Kreuter, Michael, et al.
Publicado: (2022)

Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings
por: de Jong, Lisa A., et al.
Publicado: (2019)

Real world data of anticoagulant treatment in non-valvular atrial fibrillation across renal function status
por: Calderon, Jose Miguel, et al.
Publicado: (2022)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Anticoagulation in atrial fibrillation: the present and the future
por: Dweck, Marc R, et al.
Publicado: (2012)

Anticoagulation for atrial fibrillation in active cancer
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

Treatment-dependent and treatment-independent risk factors associated with the risk of diabetes-related events: a retrospective analysis based on 229,042 patients with type 2 diabetes mellitus
por: Wilke, Thomas, et al.
Publicado: (2015)

Non-Persistence and Non-Adherence of Patients with Type 2 Diabetes Mellitus in Therapy with GLP-1 Receptor Agonists: A Retrospective Analysis
por: Wilke, Thomas, et al.
Publicado: (2015)

Effectiveness of sulphonylureas in the therapy of diabetes mellitus type 2 patients: an observational cohort study
por: Wilke, Thomas, et al.
Publicado: (2016)

P21 Social Distancing and Trends in Influenza Hospitalization during the COVID-19 Outbreak: A Difference-in-Difference Analysis of German Claims Data
por: Pacis, S, et al.
Publicado: (2022)

Safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: a retrospective analysis of contemporary Japanese administrative claims data
por: Kohsaka, Shun, et al.
Publicado: (2020)

Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world
por: Kozieł, Monika, et al.
Publicado: (2021)

Battle of oral anticoagulants in the field of atrial fibrillation scrutinized from a clinical practice (the real world) perspective
por: Altman, Raul, et al.
Publicado: (2011)

Oral Anticoagulants Initiation in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort
por: Rodríguez-Bernal, Clara L., et al.
Publicado: (2017)

Real-world oral anticoagulants for Asian patients with non-valvular atrial fibrillation: A PRISMA-compliant article
por: Kim, Seung Min, et al.
Publicado: (2021)

Real-World Prevalence of Direct Oral Anticoagulant Off-Label Doses in Atrial Fibrillation: An Epidemiological Meta-Analysis
por: Shen, Nan-Nan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_grcad0qv1vjer8h9r222ukoqve